Forlivesi, Stefano
 Distribuzione geografica
Continente #
NA - Nord America 536
EU - Europa 448
AS - Asia 242
SA - Sud America 2
AF - Africa 1
OC - Oceania 1
Totale 1.230
Nazione #
US - Stati Uniti d'America 533
CN - Cina 217
GB - Regno Unito 136
SE - Svezia 70
IE - Irlanda 46
IT - Italia 45
FR - Francia 40
DE - Germania 34
FI - Finlandia 24
UA - Ucraina 13
AT - Austria 11
SG - Singapore 9
BE - Belgio 7
RU - Federazione Russa 7
KR - Corea 5
JP - Giappone 3
PT - Portogallo 3
AE - Emirati Arabi Uniti 2
NL - Olanda 2
RS - Serbia 2
TR - Turchia 2
AU - Australia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
CL - Cile 1
CR - Costa Rica 1
CY - Cipro 1
EC - Ecuador 1
EE - Estonia 1
ES - Italia 1
GR - Grecia 1
HU - Ungheria 1
IN - India 1
IR - Iran 1
LU - Lussemburgo 1
MX - Messico 1
NO - Norvegia 1
PA - Panama 1
PL - Polonia 1
RW - Ruanda 1
Totale 1.230
Città #
Chandler 156
Southend 124
Jacksonville 48
Dublin 46
Woodbridge 40
Ashburn 38
New York 32
Beijing 31
Nanjing 24
Jinan 21
Shenyang 21
Lawrence 19
Princeton 19
Ann Arbor 16
Helsinki 15
Houston 14
Tianjin 12
Zhengzhou 12
Hebei 11
Vienna 11
Wilmington 10
Changsha 9
Lancaster 9
Nanchang 8
Hangzhou 7
Ningbo 7
Verona 7
Brussels 5
Fuzhou 5
Haikou 5
Jiaxing 5
Los Angeles 5
Singapore 5
Boardman 4
Clearwater 4
Dearborn 4
Seoul 4
Taiyuan 4
Esslingen am Neckar 3
Guangzhou 3
Lanzhou 3
Lisbon 3
Saint Louis 3
Schio 3
Taizhou 3
Washington 3
Belgrade 2
Dubai 2
Düsseldorf 2
Milan 2
Modena 2
Redwood City 2
Seattle 2
Sindelfingen 2
Tokyo 2
Waanrode 2
Ahome 1
Athens 1
Baku 1
Bologna 1
Budapest 1
Cambridge 1
Conegliano 1
Dallas 1
Edinburgh 1
Fairfield 1
Gangnam-gu 1
Harker Heights 1
Jeffries 1
Kemerovo 1
Las Vegas 1
Ludwigshafen am Rhein 1
Luxembourg 1
Madrid 1
Mumbai 1
Nave 1
Nicosia 1
Perugia 1
Phoenix 1
Puxian 1
Quito 1
Redmond 1
San José 1
Sofia 1
Stockholm 1
Tallinn 1
Warsaw 1
Xiangfen 1
Totale 893
Nome #
Benign multiple sclerosis: physical and cognitive impairment follow distinct evolutions 86
Physical disability and cognitive impairment evolution in benign multiple sclerosis: a five years prospective study 85
Reasons for exclusion from intravenous thrombolysis in stroke patients admitted to the Stroke Unit 80
Introduction of direct oral anticoagulant within 7 days of stroke onset: a nomogram to predict the probability of 3-month modified Rankin Scale score > 2 80
Stroke etiologic subtype may influence the rate of hyperdense middle cerebral artery sign disappearance after intravenous thrombolysis 78
Long-term clinical, cognitive and MRI characteristics of patients with untreated benign multiple sclerosis: a natural history study 76
Missing data on 3-month modified Rankin Scale may influence results of functional outcome after intravenous thrombolysis in observational studies 72
Cerebral large-vessel vasculitis as an unusual manifestation of POEMS syndrome 71
Association of short- and medium-term particulate matter exposure with risk of mortality after spontaneous intracerebral hemorrhage 71
Association between short- and medium-term air pollution exposure and risk of mortality after intravenous thrombolysis for stroke 70
The START nomogram for individualized prediction of the probability of unfavorable outcome after intravenous thrombolysis for stroke 66
STARTING-SICH Nomogram to Predict Symptomatic Intracerebral Hemorrhage After Intravenous Thrombolysis for Stroke 65
A nomogram to predict the probability of mortality after first-ever acute manifestations of cerebral small vessel disease 60
Number of ischemic strokes potentially eligible for revascularization treatments in an Italian Comprehensive Stroke Center: a modeling study 56
Mechanical Thrombectomy for Acute Ischemic Stroke in a Patient with Concomitant Spontaneous Intracerebral Hemorrhage 55
Early secondary prevention after initially ineffective revascularization treatments for acute ischemic stroke due to tandem occlusion 50
Changing therapeutic strategies and persistence to disease-modifying treatments in a population of multiple sclerosis patients from Veneto region, Italy 50
Intravenous thrombolysis for stroke after Dabigatran reversal with Idarucizumab: an update 49
Obesity paradox and stroke: a narrative review 42
Totale 1.262
Categoria #
all - tutte 4.385
article - articoli 4.385
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.770


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020128 17 0 0 3 20 22 11 2 29 1 7 16
2020/2021143 35 29 8 26 16 15 0 1 0 0 13 0
2021/2022157 20 60 5 11 4 0 0 9 1 1 12 34
2022/2023404 22 57 27 81 34 82 0 30 42 5 20 4
2023/2024182 4 18 8 31 27 37 2 12 0 15 22 6
2024/20256 6 0 0 0 0 0 0 0 0 0 0 0
Totale 1.262